211 related articles for article (PubMed ID: 25515747)
1. Synthesis and biological evaluation of 1,5-naphthyridines as topoisomerase I inhibitors. A new family of antiproliferative agents.
Alonso C; Fuertes M; González M; Rodríguez-Gascón A; Rubiales G; Palacios F
Curr Top Med Chem; 2014; 14(23):2722-8. PubMed ID: 25515747
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and biological evaluation of indeno[1,5]naphthyridines as topoisomerase I (TopI) inhibitors with antiproliferative activity.
Alonso C; Fuertes M; González M; Rubiales G; Tesauro C; Knudsen BR; Palacios F
Eur J Med Chem; 2016 Jun; 115():179-90. PubMed ID: 27017547
[TBL] [Abstract][Full Text] [Related]
3. Fused chromeno and quinolino[1,8]naphthyridines: Synthesis and biological evaluation as topoisomerase I inhibitors and antiproliferative agents.
Martín-Encinas E; Rubiales G; Knudsen BR; Palacios F; Alonso C
Bioorg Med Chem; 2021 Jun; 40():116177. PubMed ID: 33962152
[TBL] [Abstract][Full Text] [Related]
4. Straightforward synthesis and biological evaluation as topoisomerase I inhibitors and antiproliferative agents of hybrid Chromeno[4,3-b][1,5]Naphthyridines and Chromeno[4,3-b][1,5]Naphthyridin-6-ones.
Martín-Encinas E; Rubiales G; Knudssen BR; Palacios F; Alonso C
Eur J Med Chem; 2019 Sep; 178():752-766. PubMed ID: 31229877
[TBL] [Abstract][Full Text] [Related]
5. Dibenzo[c,h][1,5]naphthyridinediones as topoisomerase I inhibitors: design, synthesis, and biological evaluation.
Kiselev E; Empey N; Agama K; Pommier Y; Cushman M
J Org Chem; 2012 Jun; 77(11):5167-72. PubMed ID: 22587603
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, topoisomerase I and II inhibitory activity, cytotoxicity, and structure-activity relationship study of 2-phenyl- or hydroxylated 2-phenyl-4-aryl-5H-indeno[1,2-b]pyridines.
Kadayat TM; Song C; Shin S; Magar TB; Bist G; Shrestha A; Thapa P; Na Y; Kwon Y; Lee ES
Bioorg Med Chem; 2015 Jul; 23(13):3499-512. PubMed ID: 26022080
[TBL] [Abstract][Full Text] [Related]
7. Design and synthesis of novel conformationally constrained 7,12-dihydrodibenzo[b,h][1,6] naphthyridine and 7H-Chromeno[3,2-c] quinoline derivatives as topoisomerase I inhibitors: In vitro screening, molecular docking and ADME predictions.
Kardile RA; Sarkate AP; Borude AS; Mane RS; Lokwani DK; Tiwari SV; Azad R; Burra PVLS; Thopate SR
Bioorg Chem; 2021 Oct; 115():105174. PubMed ID: 34314913
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis and antiproliferative evaluation of fluorenone analogs with DNA topoisomerase I inhibitory properties.
Lee CC; Chang DM; Huang KF; Chen CL; Chen TC; Lo Y; Guh JH; Huang HS
Bioorg Med Chem; 2013 Nov; 21(22):7125-33. PubMed ID: 24094433
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and cytotoxicity of novel 20-O-linked homocamptothecin ester derivatives as potent topoisomerase I inhibitors.
Li DZ; Wang CY; Liu RH; Wang YM; Ji TF; Li YR; Pan XD
J Asian Nat Prod Res; 2013 Nov; 15(11):1179-88. PubMed ID: 24215541
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and biological evaluation of new homocamptothecin analogs.
Luo Y; Yu S; Tong L; Huang Q; Lu W; Chen Y
Eur J Med Chem; 2012 Aug; 54():281-6. PubMed ID: 22647222
[TBL] [Abstract][Full Text] [Related]
11. Synthesis of novel hybrid quinolino[4,3-b][1,5]naphthyridines and quinolino[4,3-b][1,5]naphthyridin-6(5H)-one derivatives and biological evaluation as topoisomerase I inhibitors and antiproliferatives.
Martín-Encinas E; Selas A; Tesauro C; Rubiales G; Knudsen BR; Palacios F; Alonso C
Eur J Med Chem; 2020 Jun; 195():112292. PubMed ID: 32279049
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis and evaluation of 4-substituted anthra[2,1-c][1,2,5]thiadiazole-6,11-dione derivatives as novel non-camptothecin topoisomerase I inhibitors.
Dong G; Fang Y; Liu Y; Liu N; Wu S; Zhang W; Sheng C
Bioorg Med Chem Lett; 2017 May; 27(9):1929-1933. PubMed ID: 28351590
[TBL] [Abstract][Full Text] [Related]
13. Development of 13H-benzo[f]chromeno[4,3-b][1,7]naphthyridines and their salts as potent cytotoxic agents and topoisomerase I/IIα inhibitors.
Arepalli SK; Lee C; Sim S; Lee K; Jo H; Jun KY; Kwon Y; Kang JS; Jung JK; Lee H
Bioorg Med Chem; 2018 Oct; 26(18):5181-5193. PubMed ID: 30253887
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis, and evaluation of dibenzo[c,h][1,6]naphthyridines as topoisomerase I inhibitors and potential anticancer agents.
Kiselev E; Dexheimer TS; Pommier Y; Cushman M
J Med Chem; 2010 Dec; 53(24):8716-26. PubMed ID: 21090809
[TBL] [Abstract][Full Text] [Related]
15. Antileishmanial effect of new indeno-1,5-naphthyridines, selective inhibitors of Leishmania infantum type IB DNA topoisomerase.
Tejería A; Pérez-Pertejo Y; Reguera RM; Balaña-Fouce R; Alonso C; Fuertes M; González M; Rubiales G; Palacios F
Eur J Med Chem; 2016 Nov; 124():740-749. PubMed ID: 27639365
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and Biological Evaluation of 10-Substituted Camptothecin Derivatives with Improved Water Solubility and Activity.
Yang XY; Zhao HY; Lei H; Yuan B; Mao S; Xin M; Zhang SQ
ChemMedChem; 2021 Mar; 16(6):1000-1010. PubMed ID: 33241878
[TBL] [Abstract][Full Text] [Related]
17. Synthesis of 9-(heteroarylmethylidene)amino derivatives of homocamptothecin with biological activities.
Guo W; Miao Z; Sheng C; Yao J; Liu W; Zhu L; Zhang Y; Cheng P; Dong G; Zhuang C; Zhang W
Chem Biodivers; 2011 Jul; 8(7):1266-73. PubMed ID: 21766447
[TBL] [Abstract][Full Text] [Related]
18. Synthesis of N-substituted 5-[2-(N-alkylamino)ethyl]dibenzo[c,h][1,6]naphthyridines as novel topoisomerase I-targeting antitumor agents.
Feng W; Satyanarayana M; Cheng L; Liu A; Tsai YC; Liu LF; LaVoie EJ
Bioorg Med Chem; 2008 Oct; 16(20):9295-301. PubMed ID: 18829334
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis and evaluation of thiohydantoin derivatives as potent topoisomerase I (Top1) inhibitors with anticancer activity.
Majumdar P; Bathula C; Basu SM; Das SK; Agarwal R; Hati S; Singh A; Sen S; Das BB
Eur J Med Chem; 2015 Sep; 102():540-51. PubMed ID: 26312433
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of novel benzoxanthone analogues as non-Camptothecin topoisomerase I inhibitors.
Cheng P; Zhu L; Guo W; Liu W; Yao J; Dong G; Zhang Y; Zhuang C; Sheng C; Miao Z; Zhang W
J Enzyme Inhib Med Chem; 2012 Jun; 27(3):437-42. PubMed ID: 21770860
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
